Author:
Gidda Harish,Singh Inderpal,Mohamed Ayman,Nashed Bola
Publisher
Springer Science and Business Media LLC
Reference13 articles.
1. Incretin mimetics: a novel therapeutic option for patients with type 2 diabetes - a review;Hansen KB;Diabetes Metab Syndr Obes,2010
2. DPP-4 inhibitor-related pancreatitis: rare but real!;DeVries JH;Diabetes Care,2017
3. Linagliptin-induced pancreatitis;Mosquera JE;AACE Clin Case Rep,2020
4. Linagliptin-related pancreatitis in a diabetic patient with biliary calculus: a case report;Sevencan NO;Medicine (Baltimore),2018
5. Dipeptidylpeptidase-4 inhibitors. risk of acute pancreatitis. (2012). Accessed: February 20, 2023: https://www.gov.uk/drug-safety-update/dipeptidylpeptidase-4-inhibitors-risk-of-acute-pancreatitis.